Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Jevtana/prednisone combination approved in Canada for prostate cancer

June 29, 2011

Preliminary phase I data suggest safety/activity of RO-4987655 in advanced/metastatic solid tumors

June 29, 2011

RG-7112 advances through clinical development for cancer

June 29, 2011

NK-012 shows promising activity in phase II trial in sensitive relapsed SCLC

June 29, 2011

Arno Therapeutics reports interim phase II data on AR-67 in glioblastoma multiforme

June 28, 2011

FDA lifts clinical hold on phase II Cavatak trial in melanoma

June 28, 2011

Arch Cancer Therapeutics prepares new brain tumor-targeting peptides

June 28, 2011

First-in-human study reveals activity of RAF-265 in melanoma

June 28, 2011

First-in-human data disclosed on ONX-0912 in recurrent/refractory solid tumors

June 28, 2011

First-in-human trial assesses azurin-derived P28 peptide in metastatic solid cancers

June 28, 2011

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026